General Surgery Morbidity & Mortality: Post-Op Appy Bleed with Reoperation
The General Surgery Didactic Program is an addition to Mercy Medical Center's expansive general surgery exposure. A wide variety of general surgical and subspecialty training is administered within the tertiary care facility and is taught by fellowship-trained faculty.
Nurses, physicians, surgeons, residents, medical students, and other interested health care professionals.
- Discuss the importance of evidence-based medicine and apply evidence-based medicine to each case study presented.
- Identify best practices for the surgical procedure being discussed and whether it is/was appropriate in this case.
- Critique patient outcomes for each M&M case and discuss potential improvements or different manners in which to handle.
Jan Franko, MD, PhD
Program Director, General Surgery Residency, MercyOne
Dr. Franko indicated no financial relationships to disclose relevant to the content of this continuing education activity.
Speaker(s) will disclose to attendees the nature of any financial relationships they have with the commercial firms providing support as well as the commercial manufacturers of products and/or the providers of services discussed in their presentations. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA).
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 0.75 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 0.75 AOA Category 1B